Contribution of PET/CT with Gallium 68 citrate (68Ga-PET/CT) for the diagnosis of prosthetic valve infective endocarditis - CiGal-EI-TEP
- Conditions
- Prosthetic valve infective endocarditisTherapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Investigative Techniques [E05]
- Registration Number
- CTIS2024-514331-24-00
- Lead Sponsor
- Centre Hospitalier Universitaire De Bordeaux
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 40
Adult patient (over 18 years old), Patient with a prosthetic heart valve, Patient suspected of infective endocarditis (on clinical and/or microbiological and/or imaging data), Patient whose history is discussed in the multidisciplinary meeting dedicated to endocarditis, Patient beneficiary of a social security scheme, Free, informed and written consent signed by the participant and the investigator
pregnant or breastfeeding women, women of childbearing potential not using effective contraception, patients referred to in articles L.1121-5 to L.1121-8 (persons deprived of liberty by judicial or administrative decision, minors, adults subject to a legal protection measure or unable to express their consent), Patient with cardiac surgery within 2 months of inclusion, Subject in a period of relative exclusion due to another protocol, Known contraindication to PET/CT with injection of radiotracers (hypersensitivity to radiopharmaceuticals and/or excipients)
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method